Neurometabolic changes in multiple sclerosis: Fingolimod versus beta interferon or glatiramer acetate therapy.

Oun Al-IedaniRodney LeaKaren RibbonsSaadallah RamadanJeannette Lechner-Scott

Published in: Journal of neuroimaging : official journal of the American Society of Neuroimaging (2022)

While both treatment arms showed overall similar volumetric and neurometabolic profiles, longitudinal studies are warranted to clarify neurometabolic changes and associations with treatment efficacy.

Keyphrases

multiple sclerosis
dendritic cells
white matter